NLRC5 and neoplasm: This could be attributed to the increase in the tumor mutation load, which in turn leads to the production of related new antigens8,9., we guess that NLRC5 may activate immune checkpoint and suppress immune escape by promoting dMMR of EC in the immune microenvironment, but further research is needed to prove this hypothesis.